Summary:
- Cushman & Wakefield secured a new 820 sq.m stand-alone facility in Braga for Portuguese biotech firm SilicoLife, addressing the company’s expansion and need to consolidate computational and laboratory operations.
- The move reflects SilicoLife’s growth trajectory and strategic focus on centralizing its activities to support ongoing development in biotechnology.
- In 2024, Portugal’s office market experienced notable growth in absorption volumes, particularly in its two largest cities, signaling increased demand for commercial space.
Original article:
